Omega Healthcare Investors, Inc

Valuation Analysis

About the Company

Omega Healthcare Investors, Inc en bref

Omega Healthcare Investors, Inc (OHI) is currently trading at 38,81 € with a market capitalization of 12,1 Md €. The trailing P/E ratio stands at 21.51x, with a forward P/E of 21.89x. The 52-week range spans from 31,12 € to 43,00 €; the current price is 9.8% below the yearly high. Year-over-year revenue growth stands at +14.3%. The net profit margin stands at 51.41%.

💰 Dividende

Omega Healthcare Investors, Inc currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

16 analystes évaluent Omega Healthcare Investors, Inc (OHI) au consensus : Acheter. L'objectif de cours moyen est de 44,36 €, soit un potentiel de +14.27% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 39,23 € à 54,92 €.

Omega Healthcare Investors, Inc : la thèse d'investissement en détail

Omega Healthcare Investors, Inc (OHI) operates in the Real Estate — specifically REIT - Healthcare Facilities — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Revenue is growing at a healthy 14.3% pace year-over-year, suggesting the business model continues to find new customers and pricing power. Earnings growth of 39.3% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base. With a gross margin near 99.3%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns.

Valorisation en contexte

At a PEG of 11.99, investors are paying more than three times the growth rate for each unit of earnings — that pricing assumes growth not only continues but accelerates from here.

Thèse d'investissement : forces et faiblesses

Aperçu technique

The price is in a transition zone relative to the moving averages — no clear signal.

Profil de risque

The data points to relatively defensive market behavior.

Trading Data

Related Stocks in the Same Sector

Where can I buy Omega Healthcare Investors, Inc?

Compare top-rated brokers — low fees, trusted providers, fully regulated.